P2shortA
General Information
DRACP ID DRACP05919
Peptide Name P2shortA
Sequence ALPISTVRⓍVALⓍRRL
Sequence Length 16
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Stapled Peptides Induce apoptosis Induce cell cycle arrest MDM6/MDMX Inhibitor
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
A549 | Lung adenocarcinoma | Carcinoma | 50% Killing=10 μM | Crystal violet dye | 24, 48 or 72 h | 1 |
PC-9 | Lung adenocarcinoma | Carcinoma | 80% Killing=10 μM | Crystal violet dye | 24, 48 or 72 h | 1 |
NCI-H358 | Minimally invasive lung adenocarcinoma | Carcinoma | 98% Killing=10 μM | Crystal violet dye | 24, 48 or 72 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity 74
Linear/Cyclic Cyclic (Stapled)
Disulfide/Other Bond Stapled: Ⓧ(9) and Ⓧ (13) are cross-linked by hydrocarbon stapling
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification Ⓧ=(S)-pentenylalanine
Chiral L
Physicochemical Information
Formula C70H125N23O15
Absent amino acids CDEFGHKMNQWY
Common amino acids LR
Mass 179664
Pl 12.8
Basic residues 3
Acidic residues 0
Hydrophobic residues 8
Net charge 3
Boman Index -1935
Hydrophobicity 70.63
Aliphatic Index 146.25
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32104498
Title Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available